Meeting News CoverageVideo

VIDEO: Arsenic plus decitabine effective for MDS, AML

ORLANDO — Patricia Kropf, MD, discusses study results she presented at the ASH Annual Meeting and Exposition that showed the combination of arsenic and decitabine induced improved response rates in patients with myelodysplastic syndrome and acute myeloid leukemia.

ORLANDO — Patricia Kropf, MD, discusses study results she presented at the ASH Annual Meeting and Exposition that showed the combination of arsenic and decitabine induced improved response rates in patients with myelodysplastic syndrome and acute myeloid leukemia.

    See more from ASH Annual Meeting and Exposition